Active immunotherapy in patients with hematologic and solid neoplasms
Mellstedt, H.åk.; Veelken, H.
Onkologie 28(Suppl 4): 4-8
2005
ISSN/ISBN: 0324-0959 PMID: 16285038 Document Number: 585481
Document emailed within 1 workday
Related Documents
Riera, L.; Koziner, B. 2000: Donor lymphocyte infusions as adoptive immunotherapy in patients with relapsed hematologic neoplasms post-allogenic transplant of hematopoietic progenitor cells Medicina 60(2): 259-269Nachbaur, D.; Schwaighofer, H.; Thaler, J.; Weyrer, W.; Fink, M.; Nussbaumer, W.; Fritsch, E.; Niederwieser, D. 1994: Innsbruck results of bone marrow transplantation in treatment of hematologic neoplasms and solid tumors Wiener Klinische Wochenschrift 106(7): 201-207
Grinevich, I.A. 1991: Nonspecific active immunotherapy in the combined treatment of malignant neoplasms Vrachebnoe Delo 5: 8-11
Kwiatkowski, A.; Skotnicki, A.B. 1995: Hematologic disturbances in patients with nonhematologic neoplasms. I. Anemias Przeglad Lekarski 52(8): 407-409
Wiela-Hojeńska, A.; Milejski, P.; Orzechowska-Juzwenko, K.; Usnarska-Zubkiewicz, L.; Urbaniak-Kujda, D.; Kotlarek-Haus, S. 1997: Evaluation of phenazone oxidation and sulfadimidine acetylation in patients with hematologic neoplasms Przeglad Lekarski 54(3): 163-166
Ezdinli, E.Z.; O'Sullivan, D.D.; Wasser, L.P.; Kim, U.; Stutzman, L. 1979: Oral amphotericin for candidiasis in patients with hematologic neoplasms. An autopsy study JAMA 242(3): 258-260
Tomíska, M.; Dastych, M.; Dolezalová, J.; Vorlícek, J. 1997: The effect of chemotherapy on energy and nitrogen balance in patients with hematologic neoplasms Vnitrni Lekarstvi 43(1): 18-24
Csoka, K.; Liliemark, J.; Larsson, R.; Nygren, P. 1995: Evaluation of the cytotoxic activity of gemcitabine in primary cultures of tumor cells from patients with hematologic or solid tumors Seminars in Oncology 22(4 Suppl 11: 47-53
Mor, C.; Marcovina, S.; Moro, E.; Radice, F.; Russo, R.; Trinca, E. 1978: Study of the DNCB skin test in patients with solid neoplasms Archivio Per le Scienze Mediche 135(3): 377-382
Sampi, K. 1987: Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 14(3 Part 2): 951-955
Lissoni, P.; Barni, S.; Tancini, G.; Viviani, S.; Rovelli, F.; Rescaldani, R.; Fiorelli, G. 1989: Effects of cancer chemotherapy on the relation between serum levels of soluble interleukin-2 receptors and CD4/CD8 ratio in patients with solid neoplasms Journal of Biological Regulators and Homeostatic Agents 3(3): 131-133
Fillet, G.; Bury, J.; Beguin, Y.; Duvivier, A.; Hoyoux, C.; Bours, V. 1987: Hematologic cancers in 1987. Chemotherapy and immunotherapy Revue Medicale de Liege 42(10): 496-502
Aixalá, M.; Sarandría, C.N.; Speroni, J.G. 1997: Hypocholesterolemia in hematologic neoplasms Sangre 42(1): 7-10
Morton, D.L. 2004: Immune response to postsurgical adjuvant active immunotherapy with Canvaxin polyvalent cancer vaccine: correlations with clinical course of patients with metastatic melanoma Developments in Biologicals 116: 209
2016: New immunotherapy uses defense cells against hematologic cancer. "Living medicine instead of roentgen rays Pflege Zeitschrift 69(6): 323
Okuno, K.; Sugiura, F.; Sukegawa, Y.; Inoue, K. 2012: New directions in immunotherapy for malignant solid tumors Nihon Rinsho. Japanese Journal of Clinical Medicine 70(12): 2075-2086
Trepel, F. 1971: Immunotherapy of neoplasms Medizinische Klinik 66(7): 222-229
Lejeune, F.J. 1978: Is immunotherapy a weapon in the treatment of solid neoplastic tumors? Bruxelles Medical 58(8): 401-409
Patel, A.R.; Shah, P.C.; Vohra, R.M.; Hart, W.L.; Shah, J.R. 1980: Serum ferritin levels in hematologic malignant neoplasms Archives of Pathology and Laboratory Medicine 104(10): 509-512
Huber, H.; Fasching, B.; Drach, J.; Thaler, J. 1990: Hematologic neoplasms: clinically latent--but needing treatment? Verhandlungen der Deutschen Gesellschaft für Innere Medizin 96: 138-147